Tudor Investment Corp ET AL Boosts Holdings in Select Medical Holdings Co. (NYSE:SEM)

Tudor Investment Corp ET AL grew its stake in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) by 291.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 496,724 shares of the health services provider's stock after buying an additional 369,760 shares during the period. Tudor Investment Corp ET AL owned 0.38% of Select Medical worth $9,363,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of SEM. Norges Bank purchased a new stake in Select Medical in the 4th quarter worth approximately $29,556,000. Hood River Capital Management LLC raised its position in shares of Select Medical by 404.8% in the fourth quarter. Hood River Capital Management LLC now owns 1,755,733 shares of the health services provider's stock worth $33,096,000 after buying an additional 1,407,902 shares in the last quarter. Invesco Ltd. boosted its stake in Select Medical by 48.6% during the fourth quarter. Invesco Ltd. now owns 2,643,943 shares of the health services provider's stock valued at $49,838,000 after buying an additional 864,852 shares during the period. Empowered Funds LLC bought a new position in Select Medical in the 4th quarter worth about $5,903,000. Finally, Raymond James Financial Inc. purchased a new stake in shares of Select Medical in the 4th quarter valued at about $5,858,000. 89.48% of the stock is owned by hedge funds and other institutional investors.

Select Medical Trading Down 22.0 %

Select Medical stock traded down $4.02 during mid-day trading on Friday, hitting $14.22. The company's stock had a trading volume of 4,343,374 shares, compared to its average volume of 853,554. The business has a 50 day moving average price of $16.91 and a 200-day moving average price of $21.83. Select Medical Holdings Co. has a 12 month low of $14.03 and a 12 month high of $40.98. The stock has a market cap of $1.83 billion, a price-to-earnings ratio of 8.62, a price-to-earnings-growth ratio of 0.64 and a beta of 1.38. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13.

Select Medical (NYSE:SEM - Get Free Report) last issued its earnings results on Thursday, May 1st. The health services provider reported $0.44 earnings per share for the quarter, missing the consensus estimate of $0.45 by ($0.01). The company had revenue of $1.35 billion for the quarter, compared to analysts' expectations of $1.40 billion. Select Medical had a net margin of 3.23% and a return on equity of 14.04%. The company's revenue was down 24.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.75 earnings per share. As a group, analysts forecast that Select Medical Holdings Co. will post 1.17 EPS for the current year.

Select Medical announced that its Board of Directors has authorized a share buyback program on Thursday, May 1st that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the health services provider to repurchase up to 42.6% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's board believes its shares are undervalued.

Select Medical Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, May 29th. Investors of record on Thursday, May 15th will be issued a dividend of $0.0625 per share. The ex-dividend date is Thursday, May 15th. This represents a $0.25 dividend on an annualized basis and a yield of 1.76%. Select Medical's dividend payout ratio is currently 15.15%.

Insider Buying and Selling at Select Medical

In other news, CEO David S. Chernow sold 225,000 shares of the stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $18.00, for a total transaction of $4,050,000.00. Following the completion of the sale, the chief executive officer now directly owns 714,516 shares in the company, valued at approximately $12,861,288. This represents a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 11.60% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms recently weighed in on SEM. UBS Group decreased their price objective on shares of Select Medical from $40.00 to $21.00 and set a "neutral" rating on the stock in a research report on Friday, January 3rd. Benchmark upgraded shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price objective on the stock in a research report on Monday, February 24th. Royal Bank of Canada reduced their target price on Select Medical from $47.00 to $23.00 and set an "outperform" rating on the stock in a research note on Monday, February 24th. StockNews.com raised Select Medical from a "hold" rating to a "buy" rating in a research note on Friday, February 21st. Finally, Mizuho assumed coverage on Select Medical in a research report on Wednesday, April 16th. They set an "outperform" rating and a $25.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $26.80.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.